These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2059967)

  • 1. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.
    Lando PA; Hedlund G; Dohlsten M; Kalland T
    Cancer Immunol Immunother; 1991; 33(4):231-7. PubMed ID: 2059967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.
    Belfrage H; Bhiladvala P; Hedlund G; Dohlsten M; Kalland T
    Cancer Immunol Immunother; 1994 Apr; 38(4):265-71. PubMed ID: 8168122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
    Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigen-induced lysis of melanoma cells.
    Krull F; Holzer U; Ihle J; Bethge W; Fierlbeck G; Kalland T; Dohlsten M; Niethammer D; Dannecker GE
    Melanoma Res; 1997 Jun; 7(3):214-22. PubMed ID: 9195560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
    Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
    Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.
    Dohlsten M; Lando PA; Hedlund G; Trowsdale J; Kalland T
    Immunology; 1990 Sep; 71(1):96-100. PubMed ID: 2210803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.
    Holzer U; Orlikowsky T; Zehrer C; Bethge W; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Immunology; 1997 Jan; 90(1):74-80. PubMed ID: 9038715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.
    Hedlund G; Dohlsten M; Petersson C; Kalland T
    Cancer Immunol Immunother; 1993; 36(2):89-93. PubMed ID: 8425213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
    D'Orazio JA; Burke GW; Stein-Streilein J
    J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
    Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
    Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
    Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
    D'Orazio JA; Stein-Streilein J
    Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
    Belfrage H; Dohlsten M; Hedlund G; Kalland T
    Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
    Sundstedt A; Grundström S; Dohlsten M
    Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.